| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/08/2004 | WO2003011313A8 Osteogenic growth oligopeptides as stimulants of hematopoiesis |
| 04/08/2004 | WO2003009881A3 Novel targeted delivery system for bioactive agents |
| 04/08/2004 | WO2002099074A8 Slc7s as modifiers of the p53 pathway and methods of use |
| 04/08/2004 | WO2002092008A3 Use of il-18 inhibitors for the treatement or prevention of sepsis |
| 04/08/2004 | WO2002090545A3 Nucleic acid coding for the cgl1 polypeptide and diagnostic and therapeutic application of said nucleic acid and of the cgl1 polypeptide |
| 04/08/2004 | WO2002076391B1 Microbial feeds for aquaculture and agriculture |
| 04/08/2004 | WO2002076173A3 Inhibitors of glycosaminoglycans |
| 04/08/2004 | WO2002068601A9 Small peptides capable of modulating the function of cd66 (ceacam) family members |
| 04/08/2004 | WO2002058546A3 Methods for screening for substances which inhibit fp prostanoid receptor |
| 04/08/2004 | WO2002030470A8 Methods and compositions for nucleic acid delivery |
| 04/08/2004 | US20040068380 Human gtp-rho binding protein 2 |
| 04/08/2004 | US20040068268 Devices and methods for the restoration of a spinal disc |
| 04/08/2004 | US20040068141 Process for the synthesis of trifluorophenylacetic acids |
| 04/08/2004 | US20040068105 Plant thermogenic genes and proteins |
| 04/08/2004 | US20040068099 Comprises interleukin-1 zeta polypeptides (IL-1) for diagnosis, prevention and treatment of tumors, allergies and infectious diseases |
| 04/08/2004 | US20040068095 Comprises polypeptide for diagnosis, prevention and treatment of cell proliferative, inflammatory, nervous system and autoimmune diseases |
| 04/08/2004 | US20040068094 Ring modified cyclic peptide analogs |
| 04/08/2004 | US20040068013 Supplying in situ using amino acid; immobilization |
| 04/08/2004 | US20040067933 Prevent bile acid transportation; antilipemic agents; anticholesterol agents |
| 04/08/2004 | US20040067932 Synergistic mixture; anticancer agents; therapy for skin cancer |
| 04/08/2004 | US20040067922 Pharmaceutical composition for treatment of phimosis using topical corticosteroid |
| 04/08/2004 | US20040067910 Pharmaceutical or cosmetic composition and use of a pkc inhibitor with an mmp inhibitor for inhibiting langerhans' cell migration |
| 04/08/2004 | US20040067909 Eye drops |
| 04/08/2004 | US20040067906 Compositions and methods for modulating and monitoring neurotransmitter receptor populations |
| 04/08/2004 | US20040067905 Nucleic acid compositions for stimulating immune responses |
| 04/08/2004 | US20040067903 Nucleic acids encoding a novel regulator of g protein signaling, rgs18, and uses thereof |
| 04/08/2004 | US20040067901 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/08/2004 | US20040067895 Molluscs extract; anticancer agents |
| 04/08/2004 | US20040067888 Nucleic acid capable of binding to interferons |
| 04/08/2004 | US20040067887 Nucleotide sequences; drug screening; antibody to protein |
| 04/08/2004 | US20040067886 Reducing pain; administering protein kinase c inhibitor; side effect reduction |
| 04/08/2004 | US20040067885 Use of inhibitors for the treatment of RTK-hyperfunction-induced disorders, particularly cancer |
| 04/08/2004 | US20040067884 Culture product; purified polypeptides; antiscarring agents; antiinflammatory agents |
| 04/08/2004 | US20040067883 Prevent gene expression; anticancer agents |
| 04/08/2004 | US20040067882 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/08/2004 | US20040067881 Antilipemic agents; anticholesterol agents; antidiabetic agents; hypotensive agents; administering polypeptide |
| 04/08/2004 | US20040067880 Genetic engineered fusion protein |
| 04/08/2004 | US20040067879 Effective against fungi such as Candida parapsilosis, Candida albicans, Cryptococcus neoformans, and/or Histoplasma capsulatum |
| 04/08/2004 | US20040067878 Novel lipopeptides as antibacterial agents |
| 04/08/2004 | US20040067877 Hepatitis virus infections |
| 04/08/2004 | US20040067876 Administering hemoglobulin biopolymer solution |
| 04/08/2004 | US20040067875 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 04/08/2004 | US20040067873 Compolex of apolipoproteins and sphingomyelins; anticholesterol agents |
| 04/08/2004 | US20040067586 Comprises viral nucleotide sequences coding protein for treatment of tumors; gene therapy |
| 04/08/2004 | US20040067556 Growth differentiation factor-6 |
| 04/08/2004 | US20040067553 Membrane protein for diagnosis and treatment of nervous system, endocrine, metabolic, cancer, inflamatory, respiratory, immune and infectious diseases |
| 04/08/2004 | US20040067552 Adipocyte complement related protein zacrp14 |
| 04/08/2004 | US20040067524 Chlamydia protein, gene sequence and uses thereof |
| 04/08/2004 | US20040067522 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins and uses thereof |
| 04/08/2004 | US20040067520 Given DNA sequence; Fc immunoglobulin region attached; transforming cell; use in treating obesity |
| 04/08/2004 | US20040067518 Isolated nucleic acid comprising a polynucleotide of given sequence; polypeptides; recombinant host cells; useful in diagnosing and treating disorders |
| 04/08/2004 | US20040067517 Of given amino acid sequence; binds with antibodies to the causative agent; expressed by spirochetes of Borrelia burgdorferi |
| 04/08/2004 | US20040067515 Human proteinase molecules |
| 04/08/2004 | US20040067509 Method of identifying dna encoding physiologically active polypeptide in mammalian body |
| 04/08/2004 | US20040067504 Novel zacrp8 polypeptides, polynucleotides encoding the polypeptides, and related compositions and methods of using them; useful in the study of collagen dimerization or oligomerization or in formation of fusion proteins |
| 04/08/2004 | US20040067490 Nucleic acid sequences, and antibodies that immunospecifically bind to the polypeptide, their derivatives, variants, mutants, or fragments of the novel polypeptide, polynucleotide, or antibody specific to the polypeptide |
| 04/08/2004 | US20040067259 Rapidly reducing the pressure on a supercritical or near critical fluid containing an active material to form droplets; and passing said droplets through a flow of heated gas; does not require any organic solvent. |
| 04/08/2004 | US20040067240 Therapeutic agent comprising a b-subunit of a protein toxin |
| 04/08/2004 | US20040067235 Methods for the use of neurotoxin in the treatment of urologic disorders |
| 04/08/2004 | US20040067233 Use of agiotensin II inhibitors to prevent malignancies associated with immunosuppression |
| 04/08/2004 | US20040067232 Methods for treating autoimmune diseases in a subject and in vitro diagnostic assays |
| 04/08/2004 | US20040067231 Agents for ameliorating symtoms caused by joint diseases |
| 04/08/2004 | US20040067230 Administering factor XIII. |
| 04/08/2004 | US20040067227 Prevention and reversal of dermal degeneration associated with aging, comprising administering thymosin and isoforms, to improve elasticity and reduce discolorations |
| 04/08/2004 | US20040067226 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 04/08/2004 | US20040067225 Isolated nucleic acid molecules human glucuronyltransferase proteins, and related products and processes |
| 04/08/2004 | US20040067224 Enternal formulation |
| 04/08/2004 | US20040067217 Chimeric cell-targeting pathogenic organism and method of therapeutic use |
| 04/08/2004 | US20040067197 Antiproliferative; radioisotope is located internally within a dna sequence; penetrates cell membrane and is retained intracellularly |
| 04/08/2004 | US20040066166 Motor control apparatus having current supply phase correction |
| 04/08/2004 | CA2840692A1 Fvii or fviia variants having increased clotting activity |
| 04/08/2004 | CA2523618A1 Methods for promoting dopaminergic neuronal development by using ng4a-subfamily and wnt-ligands |
| 04/08/2004 | CA2502162A1 Fvii or fviia variants having increased clotting activity |
| 04/08/2004 | CA2500468A1 Influenza therapeutic |
| 04/08/2004 | CA2500248A1 Peptide derivative fusion inhibitors of hiv infection |
| 04/08/2004 | CA2500224A1 In vivo gene silencing by chemically modified and stable sirna |
| 04/08/2004 | CA2500220A1 Composition for stimulating bone-formation and bone consolidation |
| 04/08/2004 | CA2500210A1 Cholesterol efflux and uses thereof |
| 04/08/2004 | CA2500196A1 Caspase inhibitors as anticancer agents |
| 04/08/2004 | CA2500189A1 Therapies for chronic inflammatory demyelinating polyneuropathy using interferon-.beta. |
| 04/08/2004 | CA2500120A1 Prpsc -interacting molecules and uses thereof |
| 04/08/2004 | CA2500021A1 Modified glp-1 peptides with increased biological potency |
| 04/08/2004 | CA2499983A1 Docohexaenoic acid for improved glycemic control |
| 04/08/2004 | CA2499972A1 Method for inducing mammary epithelial cell differentiation |
| 04/08/2004 | CA2499843A1 Novel compositions and methods for the treatment of psoriasis |
| 04/08/2004 | CA2499818A1 Compositions for the inhibition of protein kinase c alpha for treatment of diabetes mellitus and cardiovascular diseases |
| 04/08/2004 | CA2499580A1 Novel agents that modulate eph receptor activity |
| 04/08/2004 | CA2499253A1 Nucleoside derivatives for treating hepatitis c virus infection |
| 04/08/2004 | CA2499170A1 Methods and compositions for treatment of neurological disorder |
| 04/08/2004 | CA2498826A1 Compound binding to leukocytes and medicinal composition containing the compound in labeled state as the active ingredient |
| 04/08/2004 | CA2498483A1 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome |
| 04/08/2004 | CA2497767A1 Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy |
| 04/08/2004 | CA2497763A1 Pharmaceutical composition for improved administration of hiv gp41-derived peptides, and its use in therapy |
| 04/08/2004 | CA2494899A1 Polypeptides and nucleic acids encoding these and their use for the prevention, diagnosis or treatment of liver disorders and epithelial cancer |
| 04/07/2004 | EP1405916A1 Recombinant vaccinia virus incapable of expressing the A41L gene |
| 04/07/2004 | EP1405863A1 Concentrate of a factor VIII:C-containing von-Willebrand-factor and a process for producing it |
| 04/07/2004 | EP1405862A2 Method for the identification of antigenic peptides |
| 04/07/2004 | EP1405861A2 Analogs of parathyroid hormone |
| 04/07/2004 | EP1405644A1 Tissue-specific transporter inhibitor |
| 04/07/2004 | EP1405642A1 Pharmaceutical composition for the treatment of functional dyspepsia and/or irritable bowel syndrome and new use of substances therein |